Clinical Endoscopy

  • 제51권5호
  • /
  • Pages.407-415
  • /
  • 2018
  • /
  • 2234-2400(pISSN)
  • /
  • 2234-2443(eISSN)
대한소화기내시경학회 (The Korean Society of Gastrointestinal Endoscopy)
권호 표지
DOI QR코드

DOI QR Code

Various Intragastric Balloons Under Clinical Investigation

  • Choi, Seong Ji (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine) ;
  • Choi, Hyuk Soon (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine)
  • 투고 : 2018.08.16
  • 심사 : 2018.09.17
  • 발행 : 2018.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Obesity is a chronic disease with an exponentially increasing incidence rate, and its negative effects are well documented in numerous studies. As a result, the importance of bariatric therapy cannot be overemphasized, and many bariatric treatment methods with varying mechanisms have been developed. Of the available treatment methods, intragastric balloons, introduced in the 1980s, have been shown to be a safe and effective treatment modality; various intragastric balloon products have been developed and are currently being widely used in clinical settings. However, the disadvantages of intragastric balloons, such as unclear long-term weight loss benefits and complications experienced during insertion and removal, preclude their wider use. In this review, we discuss different intragastric balloon products, focusing on those under clinical investigation, and suggest future research directions.

키워드

과제정보

연구 과제 주관 기관 : KHIDI, NRF

참고문헌

  1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2014;384:766-781. https://doi.org/10.1016/S0140-6736(14)60460-8
  2. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J 2014;26:20-24.
  3. Grand View Research. Obesity treatment market size & forecast, by drugs (combination drugs, appetite suppressants, malabsorption & satiety drugs), by surgery & devices (adjustable gastric banding, Rouxen-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures) and trend analysis to 2024 [Internet]. San Francisco (CA): Grand View Research; c2016 [updated 2016 Sep; cited 2018 Sep 20]. Available from: https://www.grandviewresearch.com/industry-analysis/obesity-treatment-devices-and-therapeutics-market.
  4. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes 2013;20:377-388. https://doi.org/10.1097/01.med.0000433067.01671.f5
  5. Nguyen NT, Vu S, Kim E, Bodunova N, Phelan MJ. Trends in utilization of bariatric surgery, 2009-2012. Surg Endosc 2016;30:2723-2727. https://doi.org/10.1007/s00464-015-4535-9
  6. Vargas EJ, Rizk M, Bazerbachi F, Abu Dayyeh BK. Medical devices for obesity treatment: endoscopic bariatric therapies. Med Clin North Am 2018;102:149-163. https://doi.org/10.1016/j.mcna.2017.08.013
  7. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017;152:1791-1801. https://doi.org/10.1053/j.gastro.2017.01.044
  8. Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol 2016;22:5495-5504. https://doi.org/10.3748/wjg.v22.i24.5495
  9. Gleysteen JJ. A history of intragastric balloons. Surg Obes Relat Dis 2016;12:430-435. https://doi.org/10.1016/j.soard.2015.10.074
  10. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982;1:198-199.
  11. Gomez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study. Obesity (Silver Spring) 2016;24:1849-1853. https://doi.org/10.1002/oby.21555
  12. Swidnicka-Siergiejko A, Wroblewski E, Andrzej D. Endoscopic treatment of obesity. Can J Gastroenterol 2011;25:627-633. https://doi.org/10.1155/2011/174163
  13. Kentish SJ, Page AJ. The role of gastrointestinal vagal afferent fibres in obesity. J Physiol 2015;593:775-786. https://doi.org/10.1113/jphysiol.2014.278226
  14. Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg 2014;24:813-819. https://doi.org/10.1007/s11695-014-1176-3
  15. Machytka E, Gaur S, Chuttani R, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy 2017;49:154-160.
  16. Lecumberri E, Krekshi W, Matia P, et al. Effectiveness and safety of airfilled balloon Heliosphere $BAG^{(R)}$ in 82 consecutive obese patients. Obes Surg 2011;21:1508-1512. https://doi.org/10.1007/s11695-010-0314-9
  17. Almeghaiseeb ES, Ashraf MF, Alamro RA, Almasoud AO, Alrobayan AA. Efficacy of intragastric balloon on weight reduction: Saudi perspective. World J Clin Cases 2017;5:140-147. https://doi.org/10.12998/wjcc.v5.i4.140
  18. Zurawinski W, Sokolowski D, Krupa-Kotara K, Czech E, Sosada K. Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method. Wideochir Inne Tech Maloinwazyjne 2017;12:37-48.
  19. Keren D, Rainis T. Intragastric balloons for overweight populations-1 year post removal. Obes Surg 2018;28:2368-2373. https://doi.org/10.1007/s11695-018-3167-2
  20. Gaggiotti G, Tack J, Garrido AB Jr, Palau M, Cappelluti G, Di Matteo F. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg 2007;17:949-956. https://doi.org/10.1007/s11695-007-9174-3
  21. Carvalho GL, Barros CB, Okazaki M, et al. An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficiency. Obes Surg 2009;19:237-242. https://doi.org/10.1007/s11695-008-9592-x
  22. Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol 2008;42:48-53. https://doi.org/10.1097/01.mcg.0000247992.89215.88
  23. Martin CK, Bellanger DE, Rau KK, Coulon S, Greenway FL. Safety of the Ullorex oral intragastric balloon for the treatment of obesity. J Diabetes Sci Technol 2007;1:574-581. https://doi.org/10.1177/193229680700100416
  24. Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015;11:874-881. https://doi.org/10.1016/j.soard.2014.12.006
  25. US Food and Drug Administration. Summary of safety and effectiveness data (SSED): $ORBERA^{TM}$ intragastric balloon system [Internet]. Silver Spring (MD): FDA; c2015 [updated 2015 Aug 5; cited 2018 Sep 20]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf.
  26. US Food and Drug Administration. Summary of safety and effectiveness data (SSED): Obalon balloon system [Internet]. Silver Spring (MD): FDA; c2016 [updated 2016 Sep 8; cited 2018 Sep 20]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160001b.pdf.
  27. Borges AC, Almeida PC, Furlani SMT, Cury MS, Gaur S. Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience. Rev Col Bras Cir 2018;45:e1448.
  28. Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011;21:1499-1507. https://doi.org/10.1007/s11695-011-0424-z
  29. Russo T, Aprea G, Formisano C, et al. BioEnterics intragastric balloon (BIB) versus spatz adjustable balloon system (ABS): our experience in the elderly. Int J Surg 2017;38:138-140. https://doi.org/10.1016/j.ijsu.2016.06.013
  30. Daniel F, Abou Fadel C, Houmani Z, Salti N. Spatz 3 adjustable intragastric balloon: long-term safety concerns. Obes Surg 2016;26:159-160. https://doi.org/10.1007/s11695-015-1897-y
  31. Bazerbachi F, Vargas Valls EJ, Abu Dayyeh BK. Recent clinical results of endoscopic bariatric therapies as an obesity intervention. Clin Endosc 2017;50:42-50. https://doi.org/10.5946/ce.2017.013
  32. Alsabah S, Al Haddad E, Ekrouf S, Almulla A, Al-Subaie S, Al Kendari M. The safety and efficacy of the procedureless intragastric balloon. Surg Obes Relat Dis 2018;14:311-317. https://doi.org/10.1016/j.soard.2017.12.001
  33. Angrisani L, Santonicola A, Vitiello A, Belfiore MP, Belfiore G, Iovino P. Elipse balloon: the pitfalls of excessive simplicity. Obes Surg 2018;28:1419-1421. https://doi.org/10.1007/s11695-018-3148-5
  34. Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg 2010;20:1227-1230. https://doi.org/10.1007/s11695-008-9786-2
  35. Caglar E, Dobrucali A, Bal K. Gastric balloon to treat obesity: filled with air or fluid? Dig Endosc 2013;25:502-507. https://doi.org/10.1111/den.12021
  36. De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg 2010;20:1642-1646. https://doi.org/10.1007/s11695-010-0128-9
  37. Giardiello C, Borrelli A, Silvestri E, Antognozzi V, Iodice G, Lorenzo M. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg 2012;22:1916-1919. https://doi.org/10.1007/s11695-012-0786-x
  38. Drozdowski R, Wyle?ol M, Fr?czek M, Hevelke P, Giaro M, Sobanski P. Small bowel necrosis as a consequence of spontaneous deflation and migration of an air-filled intragastric balloon - a potentially life-threatening complication. Wideochir Inne Tech Maloinwazyjne 2014;9:292-296.
  39. Buzga M, Evzen M, Pavel K, et al. Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg 2014;24:909-915. https://doi.org/10.1007/s11695-014-1191-4
  40. Buzga M, Kupka T, Siroky M, et al. Short-term outcomes of the new intragastric balloon End-$Ball^{(R)}$ for treatment of obesity. Wideochir Inne Tech Maloinwazyjne 2016;11:229-235.
  41. Pezzo CT, de Souza TF, Fenero V, Suano-Souza FI, Grecco E, Sarni ROS. Efficacy and safety of intragastric balloon in the treatment of obesity in adolescent females. Nutrire 2017;42:26. https://doi.org/10.1186/s41110-017-0052-z
  42. Neto MG, Silva LB, Grecco E, et al. Brazilian intragastric balloon consensus statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis 2018;14:151-159. https://doi.org/10.1016/j.soard.2017.09.528
  43. Do TN, Ho KY, Phee SJ. A magnetic soft endoscopic capsule-inflated intragastric balloon for weight management. Sci Rep 2016;6:39486. https://doi.org/10.1038/srep39486
  44. Ghoz HM, Acosta A, Topazian M, Camilleri M, Gostout C, Dayyeh BKA. A pre-clinical animal study of combined intragastric balloon and duodenal-jejunal bypass sleeve for obesity and metabolic disease. Gastroenterology 2016;150(4 Suppl 1):S231-S232.
  45. Choi HS, Chun HJ. Recent trends in endoscopic bariatric therapies. Clin Endosc 2017;50:11-16. https://doi.org/10.5946/ce.2017.007

피인용 문헌

  1. Endoscopic Bariatric Therapy: A Guide to the Intragastric Balloon vol.114, pp.9, 2018, https://doi.org/10.14309/ajg.0000000000000239
  2. Ingestible Sensors and Sensing Systems for Minimally Invasive Diagnosis and Monitoring: The Next Frontier in Minimally Invasive Screening vol.5, pp.4, 2018, https://doi.org/10.1021/acssensors.9b02263
  3. The Efficacy and Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis vol.30, pp.9, 2018, https://doi.org/10.1007/s11695-020-04522-3
  4. Endobariatric procedures for obesity: clinical indications and available options vol.14, pp.None, 2021, https://doi.org/10.1177/2631774520984627
  5. The Clinical and Metabolic Effects of Intragastric Balloon on Morbid Obesity and Its Related Comorbidities vol.54, pp.1, 2018, https://doi.org/10.5946/ce.2020.302
  6. A Randomized, Controlled Trial Comparing the Impact of a Low-Calorie Ketogenic vs a Standard Low-Calorie Diet on Fat-Free Mass in Patients Receiving an Elipse™ Intragastric Balloon Treatment vol.31, pp.4, 2018, https://doi.org/10.1007/s11695-020-05133-8
  7. Endoscopic intragastric balloon therapy for 15 years in Japan: Results of nationwide surveys vol.14, pp.3, 2018, https://doi.org/10.1111/ases.12881
  8. Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal vol.15, pp.4, 2021, https://doi.org/10.4162/nrp.2021.15.4.456
  9. Six intragastric balloons: Which to choose? vol.13, pp.8, 2018, https://doi.org/10.4253/wjge.v13.i8.238